[Federal Register Volume 61, Number 248 (Tuesday, December 24, 1996)]
[Notices]
[Page 67842]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-32579]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Prospective Grant of Exclusive License: Intra-Urethral Prosthetic
Sphincter Valve and Intra-Urethral Valve with Integral Spring
AGENCY: Natinal Institutes of Health, Public Health Service, DHHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This is notice in accordance with 15 U.S.C. 209(c)(1) and 37
CFR 404.7(a)(1)(I) that the National Institutes of Health (NIH),
Department of Health and Human Services, in contemplating the grant of
an exclusive license in the United States to practice the invention
embodied in U.S. Patent Number 4,553,533 entitled ``Intra-Urethral
Prosthetic Sphincter Valve'' and U.S. Patent Number 5,088,980 to
AbbeyMoor Medical, Inc., having a place of business in Minneapolis,
Minnesota. The patent rights in this application have been assigned to
the Untied States of America.
The prospective exclusive license will be royalty-bearing and will
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
The prospective exclusive license may be granted unless, within 60 days
from the date of this published Notice, NIH receives written evidence
and argument that establishes that the grant of the license would not
be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
The present inventions generally relate to the urologic medical
device field of urinary dysfunction. More specifically, these
inventions relate to a non-surgically inserted prosthetic valve that
will allow patients with urinary dysfunction to void in a substantially
normal manner. The valve is fitted with a non-linear spring that avoids
false openings at unintended times and does not require undue exertion
during urination.
ADDRESSES: Requests for a copy of these patents, inquiries, comments,
and other materials relating to the contemplated license should be
directed to: John Fahner-Vihtelic, Office of Technology Transfer,
National Institutes of Health, 6011 Executive Boulevard, Suite 325,
Rockville, Maryland 20852-3804; Telephone: 301/496-7735 extension 285;
Fax: 301/402-0220. Properly filed competing applications for a license
filed in response to this notice will be treated as objections to the
contemplated license. Only written comments and/or applications for a
license which are received by the NIH Office of Technology Transfer on
or before February 24, 1997 will be considered. Comments and objections
submitted in response to this notice will not be made available for
public inspection, and, to the extent permitted by law, will not be
released under the Freedom of Information Act, 5 U.S.C. 552.
Dated: December 11, 1996.
Barbara M. McGarey,
Deputy Director, Office of Technology Transfer.
[FR Doc. 96-32579 Filed 12-23-96; 8:45 am]
BILLING CODE 4140-01-M
